Document Detail

Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases.
MedLine Citation:
PMID:  20508948     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Bisphosphonates (BPs) are bone-remodeling inhibitors that are used to manage bone metastases and osteoporosis. Osteonecrosis of the jaw, however, can occur during treatment. This complication is poorly understood and is called "bisphosphonate-induced osteonecrosis of the jaw" (BIOJ). METHODS: We performed a PubMed-based review of all of the described cases of BIOJ from January 2003 (the year of the first description) to September 2009. Issues of clinical relevance, such as the primary diagnosis and type of treatment, were evaluated for each patient case. RESULTS: We retrieved 2,408 cases, 88% of which were associated with intravenous therapy, primarily with zoledronate. Of the total number of cases, 89% were associated with the treatment of a malignant condition, particularly multiple myeloma (43% of the cases). Of all the BIOJ cases, 67% were preceded by tooth extraction and only 35% of patients were cured. CONCLUSION: Prevention is better than treatment, and the establishment of meticulous oral hygiene and surgical procedures prior to commencing BP treatment is important for preventing BIOJ. Our review summarizes the current knowledge about this severe complication. Future studies, especially basic research studies, are needed to better understand this devastating disease.
O Filleul; E Crompot; S Saussez
Related Documents :
20633258 - Managing hyperemesis gravidarum: a multimodal challenge.
348118 - Childhood pemphigus treated with gold.
25238968 - An amazing case of fatal self-immolation.
12802608 - Pediatric sand aspiration: case report and literature review.
576528 - Five cases of absence of iodide concentrating mechanism.
23099968 - Forked rib: an autopsy case report and discussion on its clinical implications.
Publication Detail:
Type:  Journal Article; Review     Date:  2010-05-28
Journal Detail:
Title:  Journal of cancer research and clinical oncology     Volume:  136     ISSN:  1432-1335     ISO Abbreviation:  J. Cancer Res. Clin. Oncol.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-06-21     Completed Date:  2010-07-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902060     Medline TA:  J Cancer Res Clin Oncol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1117-24     Citation Subset:  IM    
Faculty of Medicine and Pharmacy, Department of Anatomy and Cellular Biology, University of Mons, Pentagone 2C-Avenue du Champ de Mars, 6, B-7000, Mons, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Remodeling / drug effects*
Diphosphonates / adverse effects*,  therapeutic use
Jaw Diseases / chemically induced*,  pathology
Mandibular Diseases / chemically induced,  pathology,  surgery
Maxilla / pathology,  surgery
Maxillary Diseases / chemically induced,  pathology,  surgery
Osteitis Deformans / chemically induced
Osteonecrosis / chemically induced*,  pathology,  surgery,  therapy*
Retrospective Studies
Sex Ratio
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biolo...
Next Document:  Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and pro...